About 2 months of the estimated/stated duration (9 months) of the pharma negotiations has passed. Herantis’ board has certainly been meeting intensively, and a decision regarding the future will likely soon be ready for a stock exchange release.
Only the stock market’s “neighbor envy” keeps this in a grip, but for how long.
Actually, no negative press releases or actions have been seen in this company’s operations or development work for many years.